Delivery Order SPE2D021DA002-SPE2D326F2396
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order on September 10, 2025, by the Medical Supply Chain division of the Department of Defense. The contract, valued at $1,742.50 with an ultimate completion date of September 15, 2025, covers the supply of Epinephrine 0.3 mg auto-injector 2-packs. This delivery order was issued without a set-aside designation, allowing the company to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,053.25 for epinephrine 0.3 mg auto-injector supplies on November 26, 2025. This firm fixed-price delivery order was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain division, with an ultimate completion date of November 28, 2025. The award is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,515.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector units. The delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and carries no set-aside designation, indicating the award was made through open competition. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,045.50. Issued on December 1, 2025, with an ultimate completion date of December 2, 2025, this firm fixed-price delivery order represents a routine procurement under the company's existing pharmaceutical supply contract....
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, valued at $2,590.25, was awarded on November 26, 2025, with completion scheduled for November 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,613.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued under DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $3,833.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted...
- The U.S. Department of Defense Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine auto-injectors. The delivery order, valued at $1,329.28 with a firm fixed-price structure, was awarded on October 15, 2025, with an ultimate completion date of October 27, 2025. This award carries no set-aside designation, demonstrating the contractor's competitive standing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,119.84 for epinephrine injections on September 2, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a specific task order issued under DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,045.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation, demonstrating the company's competitive capability in unrestricted federal contracting. The delivery...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F2396Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,742.50 on December 10, 2025, for the supply of epinephrine 0.3 mg auto-injector units. This firm fixed-price delivery order, which carries an ultimate completion date of December 11, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense agency component responsible for pharmaceutical procurement to support Department of Defense operations. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, has a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's inclusion as a prime vendor contractor under this initiative positions it as a critical supplier for emergency medications and specialized pharmaceuticals essential to Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/9/25 |